Alicia Fong, OncoDerm Research at Mount Sinai Health System and Hematology/Oncology Scribe at NewYork-Presbyterian, shared on LinkedIn:
“In this MedNews Week episode, Dr. Douglas Flora explores how artificial intelligence could advance oncology, from recognizing tumor-related signals in blood to matching patients with clinical trials and supporting clinical decision-making.
We discussed the potential of multi-cancer detection, circulating tumor DNA (ctDNA), and AI-assisted drug discovery, while emphasizing the need for clinical validation, equitable access, and human oversight.
Swipe through this carousel for key takeaways, then watch the full episode on OncoDaily TV for the clinical context.”
Other articles about Precision Oncology on OncoDaily.
